Steven Barnes, PhD, Selected to Receive Five-Year NIH Research Grant


Pasadena, CA, August 28, 2023 – Steven Barnes, PhD, Principal Investigator at Doheny Eye Institute and Professor of Ophthalmology and Neurobiology at UCLA’s David Geffen School of Medicine, was selected to receive a five-year grant from the National Institutes of Health (NIH) for his research on retinal ganglion cell signaling regulated by intrinsic reactive oxygen species. This work is crucial for deciphering the complexities of retinal health and disease. It holds the potential to transform the approach to diagnosis, treatment, and prevention of neurodegenerative eye disorders, ultimately benefiting countless individuals worldwide.

Dr. Barnes received a Research Project Grant (R01), a significant source of financial support awarded by the NIH in the United States. The grant is also a symbol of excellence and a catalyst for groundbreaking research that has the potential to transform scientific knowledge, improve patient outcomes, and drive progress in vision health.

“As we continue to work towards bettering our understanding of ocular diseases and vision research, this grant will help us move the depth of our knowledge further,” says Dr. Barnes.

This grant is a shining example of the recognition that Doheny Eye Institute continues to receive for its innovative research. These accolades not only reinforce Doheny’s stellar reputation as a leader in vision science, but also provide the essential funding needed to advance the ongoing efforts of the non-profit organization.

Doheny Eye Institute continues to attract national attention for its work and brings in top researchers and clinician-scientists to collaborate on important research.  Doheny scientists have developed novel eye imaging equipment and computer-based retinal image analysis, implanted the first successful retinal prosthesis, identified retinal biomarkers for Alzheimer’s Disease and developed multiple animal models of ocular disease – with groundbreaking research continuing every day.

Doheny leadership extends a heartfelt congratulations to Dr. Barnes for the dedicated efforts that led to the acquisition of this grant. This award will serve as a steadfast pillar of support for ocular research, striving tirelessly to enhance the quality of life for patients and elevate the standard of their care.

Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Number R01EY033905. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


For more information contact:

Molly Ann Woods
Chief Development and Communications Officer



Share this with your friends!